Validation of proposed cIMPACT-NOW update 12 molecular grading criteria for IDH-mutant astrocytoma
Year: 2026
Type: article
Source: Acta Neuropathologica
Authors: Timothy E. Richardson, Jorge Samanamud, Michael Christian Virata, Ema Mir, Shrishtee Kandoi, Cheyanne C. Slocum, Diana D. Shi, Milan R. Savani, Raquel T. Yokoda, Sachein Sharma, Raymund L. Yong, Joshua B. Bederson, Thenzing J. Silva-Hurtado, Phuong Nguyen, Satomi Hiya, Carolina Maldonado-Díaz, Kevin Clare, Meenakshi Vij, Yurika Nishikawa, Melissa Umphlett, Kimmo J. Hatanpaa, Steven Brem, Mariano S. Viapiano, Matija Snuderl, Dolores Hambardzumyan, Jamie M. Walker, Kalil G. Abdullah, Samuel K. McBrayer, Nadejda M. Tsankova
Institutions: Icahn School of Medicine at Mount Sinai, Children's Medical Center, Harvard University, Massachusetts General Hospital, Mass General Brigham, The University of Texas Southwestern Medical Center, Mayo Clinic, Mayo Clinic Hospital, Caris Life Sciences (United States), Tisch Cancer Institute, University of Pennsylvania, SUNY Upstate Medical University, NYU Langone Health, New York University, University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Harold C. Simmons Comprehensive Cancer Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,990
Funders: Eli Lilly and Company, Servier
OpenAlex ID: W7170083735